Axsome Therapeutics (AXSM) Interest Coverage Ratio Growth (1y) (2016 - 2026)
Axsome Therapeutics (AXSM) Interest Coverage Ratio Growth (1y) (2016 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,861.65 Bn | 66,861.36 Bn | - | -60.44% |
| 2 | Nanobiotix | 1,911.83 Bn | 1,911.77 Bn | - | - |
| 3 | Akari Therapeutics | 973.81 Bn | 973.81 Bn | - | -347.04% |
| 4 | BeOne Medicines | 471.51 Bn | 466.72 Bn | 1.35 Bn | 787.12% |
| 5 | Vertex Pharmaceuticals | 121.94 Bn | 114.70 Bn | 2.59 Bn | 53.59% |
| 6 | Regeneron Pharmaceuticals | 70.05 Bn | 61.30 Bn | 3.31 Bn | -32.04% |
| 7 | Belite Bio | 62.68 Bn | 62.68 Bn | - | - |
| 8 | Argenx Se | 55.88 Bn | 50.69 Bn | 1.41 Bn | - |
| 9 | Alnylam Pharmaceuticals | 37.49 Bn | 34.48 Bn | 959.66 Mn | 1,378.45% |
| 10 | Axsome Therapeutics | 12.25 Bn | 11.94 Bn | 176.48 Mn | -11.19% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -11.19% |
| Dec 31, 2025 | -166.09% |
| Sep 30, 2025 | 84.24% |
| Jun 30, 2025 | 90.13% |
| Mar 31, 2025 | 15.07% |
| Dec 31, 2024 | 166.24% |
| Sep 30, 2024 | -0.54% |
| Jun 30, 2024 | -19.65% |
| Mar 31, 2024 | -952.65% |
| Dec 31, 2023 | 13.44% |
| Sep 30, 2023 | -2,589.49% |
| Jun 30, 2023 | -2,376.48% |
| Mar 31, 2023 | 97.06% |
| Dec 31, 2022 | 18.25% |
| Sep 30, 2022 | -100.21% |
| Jun 30, 2022 | -148.87% |
| Mar 31, 2022 | -39.93% |
| Dec 31, 2021 | 5.60% |
| Sep 30, 2021 | -83.13% |
| Jun 30, 2021 | -142.04% |